P/36/2011

Key facts

Active substance
  • Recombinant human granulocyte colony stimulating factor
  • recombinant human albumin fusion protein
Therapeutic area
Oncology
Decision number
P/36/2011
PIP number
P/36/2011
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Prevention of chemotherapy induced neutropenia
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Teva Pharmaceuticals Europe B.V
info@ratiopharm.de
Germany
Phone: +49 73140202
Fax: +49 7314027832
Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating